Holocene Advisors
RXST icon

Holocene Advisors’s RxSight RXST Stock Holding History

Holocene Advisors’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.94M Buy
315,250
+51,830
+20% +$430K ﹤0.01% 573
2025
Q4 		$2.74M Buy
+263,420
New +$2.64M 0.01% 458
2024
Q3 		– Sell
-24,497
Closed -$1.47M – 839
2024
Q2 		$1.47M Buy
+24,497
New +$1.4M 0.01% 567

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Holocene Advisors's RXST Position: Q1 2026 in Review

Holocene Advisors increased its RxSight (RXST) stake by 20% in Q1 2026, buying an estimated $430K and bringing the position to 315,250 shares worth $1.94M. The position accounts for ﹤0.01% of the portfolio, ranked #573.

Holocene Advisors first reported a position in RXST in Q2 2024 and has held it in 3 quarters since. The position peaked at $2.74M in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Holocene Advisors held 315,250 shares of RxSight worth $1.94M as of Q1 2026.
  • Holocene Advisors bought 51,830 RxSight shares in Q1 2026, an estimated $430K.
  • RxSight made up ﹤0.01% of Holocene Advisors's portfolio in Q1 2026, its #573 holding.
  • Holocene Advisors first reported a position in RxSight in Q2 2024 and has held it in 3 quarters since.
  • Holocene Advisors's RxSight position peaked at $2.74M in Q4 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.